NEW YORK (GenomeWeb News) – EMD Millipore said today that its Discovery and Development Solutions business has received CLIA certification for its contract research lab located in St. Louis.

The Billerica, Mass.-based division of Germany's Merck KGaA said that the Discovery and Development Solutions business develops and performs immunoassays on human and animal samples and offers biomarker analysis for an array of therapeutic applications including diabetes, infection, neurodegenerative disease, osteoporosis, and cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.